4
Changes in Ownership
HERON THERAPEUTICS, INC. /DE/ Filed Acc 0000950170-25-007545
Chief Executive Officer acquired 13,797 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Collard Craig A Chief Executive Officer | 2025-01-19 | Option exercise | +13,797 | 314,867 | D: show line 1 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Collard Craig A Chief Executive Officer | 2025-01-19 | Option exercise · Restricted Stock Units | −13,797 | 165,562 | D: show line 2 in the form |
Loading xslF345X05/ownership.xml…